118 related articles for article (PubMed ID: 31957819)
1. MiRNA-96 accelerates the malignant progression of ovarian cancer via targeting FOXO3a.
Yang N; Zhang Q; Bi XJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):65-73. PubMed ID: 31957819
[TBL] [Abstract][Full Text] [Related]
2. LINC01308 accelerates the malignant progression of ovarian cancer by binding to miRNA-506.
Zhang YY; Li P; Zhu MZ; Guo Y; Yang J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3253-3260. PubMed ID: 31081077
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
Sun D; Fan XH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MIF-AS1 aggravates the progression of ovarian cancer by sponging miRNA-31-5p.
Fan Y; Wang L; Han XC; Ma HY; Zhang N; Zhe L
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2248-2255. PubMed ID: 32196575
[TBL] [Abstract][Full Text] [Related]
5. LncRNA DANCR aggravates the progression of ovarian cancer by downregulating UPF1.
Pei CL; Fei KL; Yuan XY; Gong XJ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10657-10663. PubMed ID: 31858532
[TBL] [Abstract][Full Text] [Related]
6. PKMYT1 aggravates the progression of ovarian cancer by targeting SIRT3.
Xuan ZH; Wang HP; Zhang XN; Chen ZX; Zhang HY; Gu MM
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5259-5266. PubMed ID: 32495859
[TBL] [Abstract][Full Text] [Related]
7. CircRNA_MYLK promotes malignant progression of ovarian cancer through regulating microRNA-652.
Zhao Y; Hu Y; Shen Q; Chen Q; Zhu XJ; Jiang SS; Zhang Q
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5281-5291. PubMed ID: 32495861
[TBL] [Abstract][Full Text] [Related]
8. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
[TBL] [Abstract][Full Text] [Related]
9. TRIM24 aggravates the progression of ovarian cancer through negatively regulating FOXM1 level.
Zhou HE; Pan SS; Han H
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10647-10656. PubMed ID: 31858531
[TBL] [Abstract][Full Text] [Related]
10. LncRNA AK024094 aggravates the progression of breast cancer through regulating miRNA-181a.
Zheng TZ; Li YT; Li WJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1913-1921. PubMed ID: 32141560
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-8073 targets ZnT1 to inhibit malignant progression of ovarian cancer.
Zhang L; Wang YH; Wang L
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6062-6069. PubMed ID: 31364107
[TBL] [Abstract][Full Text] [Related]
12. CircRNA UBAP2 promotes the progression of ovarian cancer by sponging microRNA-144.
Sheng M; Wei N; Yang HY; Yan M; Zhao QX; Jing LJ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7283-7294. PubMed ID: 31539115
[TBL] [Abstract][Full Text] [Related]
13. LncRNA CACS15 accelerates the malignant progression of ovarian cancer through stimulating EZH2-induced inhibition of APC.
Liu Y; Sun J; Yu J; Ge W; Xiao X; Dai S; Xiang Q
Am J Transl Res; 2019; 11(10):6561-6568. PubMed ID: 31737207
[TBL] [Abstract][Full Text] [Related]
14. PCAT1 promotes the proliferative and migratory potentials of ovarian cancer via targeting NEK2.
Liu XL; Liu HM; Han N; Li FH; Sun F; Fan DM; Xu Q
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8239-8248. PubMed ID: 31646554
[TBL] [Abstract][Full Text] [Related]
15. LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4.
Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
Biomed Pharmacother; 2019 Nov; 119():109431. PubMed ID: 31514068
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SND1-IT1 accelerates the proliferation and migration of osteosarcoma via sponging miRNA-665 to upregulate POU2F1.
Jin XM; Xu B; Zhang Y; Liu SY; Shao J; Wu L; Tang JA; Yin T; Fan XB; Yang TY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9772-9780. PubMed ID: 31799644
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-206 suppresses the metastasis of osteosarcoma via targeting Notch3.
Cai WT; Guan P; Lin MX; Fu B; Wu B; Wu J
J Biol Regul Homeost Agents; 2020; 34(3):775-783. PubMed ID: 32627519
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-584 suppresses the progression of ovarian cancer by negatively regulating LPIN1.
Yang L; Ma HL
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1062-1071. PubMed ID: 32096176
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.
Xia XY; Yu YJ; Ye F; Peng GY; Li YJ; Zhou XM
Neoplasma; 2020 Mar; 67(2):344-353. PubMed ID: 31973537
[TBL] [Abstract][Full Text] [Related]
20. LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2.
Wang L; Ye TY; Wu H; Chen SY; Weng JR; Xi XW
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):201-208. PubMed ID: 31389610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
